Mitigation Strategies N(%) | |
---|---|
ARV Adherence Strategies | |
Multi-month dispensation of ARV medicationa | 11 (78.6%) |
Alternative drug delivery (i.e., delivery via postal/courier, home/community delivery, or pick-up) | 11 (78.6%) |
Use of staff working at home to contact patients remotely to inquire about perceived barriers to regimen maintenance throughout the pandemic | 7 (50%) |
Appointment Strategies | |
Use of staff working at home to contact patients remotely to encourage appointment attendance | 9 (64.3%) |
Provision of appointment reminders to patients with missing viral load measures (w/in 6-month window) | 7 (50%) |
Prioritization of appointments to patients without viral load measures (w/in 6-month window) | 7 (50%) |
Prioritization of appointments for those with changes in their health | 7 (50%) |
Reorganization of appointments, only allowing scheduled visits | 6 (42.9%) |
Prioritization of appointments for those without HIV/related illness symptoms | 2 (14.3%) |
Organizational Changes/Modifications | |
Reduced clinic hours | 5 (35.7%) |
Mobile clinics to reach patients | 2 (14.3%) |
Scale up HIV self-testing | 2 (14.3%) |
Added new staff | 2 (14.3%) |
Extended clinic hours | 1 (7.1%) |
Laid off/furloughed staff | 0 (0%) |
Reduced staff hours | 0 (0%) |
Reduced Staff salaries | 0 (0%) |
Strategies for Identifying and Supporting Those Lost to Follow-Up During the Pandemic | |
Provider offered care to persons with any income level and insurance status* | 9 (64.3%) |
Use e-prescribing for auto refills, even if the patient missed visits* | 8 (57.1%) |
Use CRISP** to check for hospitalizations of lost patients | 8 (57.1%) |
Systematic monitoring of retention in care (e.g., monitoring visit adherence, gaps in care, or visits per interval of time)* | 7 (50%) |
Provided patients navigation services (accompanying to appointments as needed)* | 7 (50%) |
Check vital records for death certificates of patients lost to follow-up | 1 (7.1%) |